Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds

Here we provide a literature database for flavonoids, focused upon quercetin, rutin, isorhamnetin, and their related compounds. Original papers and reviews about in vitro, in vivo, and clinical pharmacologies are contained here.

Search

Result:: 2531-2540 Hits of 2587

Anti-hyperglycemic activity of Rutin in streptozotocin-induced diabetic rats: An effect mediated through cytokines, antioxidants and lipid biomarkers

Authors:: Netaji T. Niture; Ansar A. Ansari; Suresh R. Naik

Reference:: Indian Journal of Experimental Biology; 2014; 52; 720-727

DOI:: ?

See Abstract

Neuroprotective Effects of Rutin in Streptozotocin-Induced Diabetic Rat Retina

Authors:: Mohammad Shamsul Ola; Mohammed M. Ahmed; Rehan Ahmad; Hatem M. Abuohashish; Salim S. Al-Rejaie; Abdullah S. Alhomida

Reference:: Journal of Molecular Neuroscience; 2015; 56; 440–448

DOI:: 10.1007/s12031-015-0561-2

See Abstract

Quercetin oppositely regulates insulin-mediated glucose disposal in skeletal muscle under normal and inflammatory conditions: The dual roles of AMPK activation

Authors:: Kang Liu; Fan Mei; Yapu Wang; Na Xiao; Lele Yang; Yilei Wang; Jia Li; Fang Huang; ,Junping Kou; Baolin Liu; Lian-Wen Qi

Reference:: Molecular Nutrition & Food Research; 2016; 60; 551-565

DOI:: 10.1002/mnfr.201500509

See Abstract

Rutin ameliorates diabetic neuropathy by lowering plasma glucose and decreasing oxidative stress via Nrf2 signaling pathway in rats

Authors:: Ruifeng Tian; Wenqing Yang; Qiang Xue; Liang Gao; Junli Huo; Dongqing Ren; Xiaoyan Chen

Reference:: European Journal of Pharmacology; 2016; 771; 84-92

DOI:: 10.1016/j.ejphar.2015.12.021

See Abstract

Rutin suppresses human-amylin/hIAPP misfolding and oligomer formation in-vitro, and ameliorates diabetes and its impacts in human-amylin/hIAPP transgenic mice

Authors:: Jacqueline F. Aitken; Kerry M. Loomes; Isabel Riba-Garcia; Richard D. Unwin; Gordana Prijic; Ashley S. Phillips; Anthony R. J. Phillips; Donghai Wu; Sally D. Poppitt; Ke Ding; Perdita E. Barran; Andrew W. Dowsey; Garth J. S. Cooper

Reference:: Biochemical and Biophysical Research Communications; 2017; 482; 625-631

DOI:: 10.1016/j.bbrc.2016.11.083

See Abstract

Quercetin and pioglitazone synergistically reverse endothelial dysfunction in isolated aorta from fructose-streptozotocin (F-STZ)-induced diabetic rats

Authors:: Thubasni Kunasegaran; Mohd Rais Mustafa; Francis I. Achike; Dharmani Devi Murugan

Reference:: European Journal of Pharmacology; 2017; 799; 160-170

DOI:: 10.1016/j.ejphar.2017.02.022

See Abstract

Combination of ramipril and rutin alleviate alloxan induced diabetic nephropathy targeting multiple stress pathways in vivo

Authors:: Divya Ganesan; Ashlesha Holkar; Abhishek Albert; Eldho Paul; Jayalakshmi Mariakuttikan; Govindan Sadasivam Selvam

Reference:: Biomedicine & Pharmacotherapy; 2018; 108; 1338-1346

DOI:: 10.1016/j.biopha.2018.09.142

See Abstract

Enhancement of glyoxalase 1, a polyfunctional defense enzyme, by quercetin in the brain in streptozotocin-induced diabetic rats

Authors:: Xia Zhu; Ya-qin Cheng; Qian Lu; Lei Du; Xiao-xing Yin; Yao-wu Liu

Reference:: Naunyn-Schmiedeberg's Archives of Pharmacology; 2018; 391; 1237–1245

DOI:: 10.1007/s00210-018-1543-z

See Abstract

Isoquercetin ameliorates hyperglycemia and regulates key enzymes of glucose metabolism via insulin signaling pathway in streptozotocin-induced diabetic rats

Authors:: Muthukumaran Jayachandran; Tongze Zhang; Kumar Ganesan; Baojun Xu; Stephen Sum Man Chung

Reference:: European Journal of Pharmacology; 2018; 829; 112-120

DOI:: 10.1016/j.ejphar.2018.04.015

See Abstract

Hypoglycemic effect and mechanism of isoquercitrin as an inhibitor of dipeptidyl peptidase-4 in type 2 diabetic mice

Authors:: Lei Zhang; Shi-Tao Zhang; Yan-Chun Yin; Shu Xing; Wan-Nan Li; Xue-Qi Fu

Reference:: RSC Advances; 2018; 8; 14967–14974

DOI:: 10.1039/c8ra00675j

See Abstract